Thomas Enke
Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Ducts | 1 | 2025 | 81 | 0.850 |
Why?
| | Endoscopy, Digestive System | 1 | 2025 | 141 | 0.810 |
Why?
| | Esophagoscopy | 1 | 2026 | 223 | 0.810 |
Why?
| | Laser Therapy | 1 | 2025 | 146 | 0.780 |
Why?
| | Hepatitis, Autoimmune | 1 | 2023 | 11 | 0.760 |
Why?
| | Barrett Esophagus | 1 | 2026 | 172 | 0.760 |
Why?
| | Cholestasis | 1 | 2025 | 217 | 0.740 |
Why?
| | Liver Failure, Acute | 1 | 2023 | 78 | 0.710 |
Why?
| | Brain Diseases | 1 | 2023 | 159 | 0.680 |
Why?
| | Esophageal Neoplasms | 1 | 2026 | 351 | 0.680 |
Why?
| | Adenocarcinoma | 2 | 2026 | 927 | 0.620 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2026 | 1160 | 0.570 |
Why?
| | Liver Transplantation | 1 | 2023 | 751 | 0.460 |
Why?
| | Follow-Up Studies | 2 | 2026 | 5439 | 0.230 |
Why?
| | Bile Ducts | 1 | 2025 | 66 | 0.220 |
Why?
| | Colonic Polyps | 1 | 2026 | 87 | 0.220 |
Why?
| | Constriction, Pathologic | 1 | 2025 | 240 | 0.210 |
Why?
| | Colonoscopy | 1 | 2026 | 257 | 0.200 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2025 | 218 | 0.190 |
Why?
| | Coma | 1 | 2023 | 39 | 0.190 |
Why?
| | Bilirubin | 1 | 2023 | 101 | 0.180 |
Why?
| | Recurrence | 1 | 2026 | 1133 | 0.180 |
Why?
| | Proportional Hazards Models | 1 | 2026 | 1331 | 0.180 |
Why?
| | Stents | 1 | 2025 | 554 | 0.170 |
Why?
| | Treatment Outcome | 2 | 2026 | 11821 | 0.160 |
Why?
| | Hypertension, Portal | 1 | 2020 | 66 | 0.150 |
Why?
| | Incidence | 1 | 2026 | 2936 | 0.140 |
Why?
| | Venous Thrombosis | 1 | 2020 | 199 | 0.140 |
Why?
| | Colorectal Neoplasms | 1 | 2026 | 874 | 0.130 |
Why?
| | Retrospective Studies | 2 | 2025 | 17438 | 0.110 |
Why?
| | Aged | 2 | 2026 | 26432 | 0.110 |
Why?
| | Time Factors | 1 | 2026 | 7109 | 0.110 |
Why?
| | DNA, Neoplasm | 1 | 2014 | 160 | 0.100 |
Why?
| | Prognosis | 1 | 2023 | 4351 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2014 | 149 | 0.100 |
Why?
| | Prospective Studies | 1 | 2026 | 8123 | 0.100 |
Why?
| | Middle Aged | 2 | 2026 | 36619 | 0.090 |
Why?
| | Humans | 6 | 2026 | 146342 | 0.080 |
Why?
| | Male | 3 | 2026 | 73396 | 0.070 |
Why?
| | Female | 2 | 2026 | 79499 | 0.060 |
Why?
| | Prostatic Neoplasms | 1 | 2014 | 972 | 0.060 |
Why?
| | Endoscopic Mucosal Resection | 1 | 2026 | 41 | 0.060 |
Why?
| | Adult | 2 | 2023 | 41087 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 319 | 0.040 |
Why?
| | Portal Vein | 1 | 2020 | 123 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2020 | 278 | 0.030 |
Why?
| | Inpatients | 1 | 2020 | 540 | 0.030 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2014 | 40 | 0.030 |
Why?
| | Radionuclide Imaging | 1 | 2014 | 116 | 0.030 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2014 | 141 | 0.030 |
Why?
| | Iodine Radioisotopes | 1 | 2014 | 139 | 0.030 |
Why?
| | Prostate | 1 | 2014 | 159 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1041 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 447 | 0.020 |
Why?
| | Cell Survival | 1 | 2014 | 1105 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2502 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3545 | 0.010 |
Why?
|
|
Enke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|